Skip to main content

Table 1 Baseline characteristics in the development group and validation group

From: Pulmonary infection after cardiopulmonary bypass surgery in children: a risk estimation model in China

Variable (%)

Development group(n = 1776)

Validation group(n = 395)

PI (n = 580)

non-PI (n = 1196)

P Value

PI (n = 128)

non-PI (n = 267)

P Value

Sex

  

0.782

  

0.624

 Male

312(53.8)

635 (53.1)

 

70 (54.7)

139 (52.1)

 

 Female

268 (46.2)

561 (46.9)

 

58 (45.3)

128 (47.9)

 

Age (month)

  

<.001

  

<.001

 < 6

110 (19.0)

65 (5.4)

 

24 (18.7)

10 (3.8)

 

 6–11.99

187 (32.2)

185 (15.5)

 

34 (26.6)

46 (17.2)

 

 12–23.99

154 (26.6)

271 (22.7)

 

48 (37.5)

70 (26.2)

 

 > = 24

129 (22.2)

675 (56.4)

 

22 (17.2)

141 (52.8)

 

Weight (kg)

  

<.001

  

<.001

 < 5

63 (10.9)

21 (1.8)

 

17 (13.3)

6 (2.3)

 

 5–7.99

231 (39.8)

240 (20.0)

 

55 (43.0)

54 (20.2)

 

 8–13.99

230 (39.7)

520 (43.5)

 

50 (39.1)

134 (50.2)

 

 > = 14

56 (9.6)

415 (34.7)

 

6 (4.6)

73 (27.3)

 

PAH

  

0.251

  

0.965

 YES

249 (42.9)

548 (45.8)

 

51 (39.8)

107 (40.1)

 

 NO

331 (57.1)

648 (54.2)

 

77 (60.2)

160 (59.9)

 

RACHS-1

  

<.001

  

<.001

 <=2

280 (48.3)

1106 (92.5)

 

56 (43.8)

256 (95.9)

 

 > = 3

300 (51.7)

90 (7.5)

 

72 (56.2)

11 (4.1)

 

Preoperative hospital stay (min)

  

<.001

  

<.001

 < 125

156 (26.9)

643 (53.8)

 

31 (24.2)

132 (49.4)

 

 125–174.99

179 (30.9)

365 (30.5)

 

44 (34.4)

78 (29.2)

 

 175–224.99

89 (15.3)

115 (9.6)

 

21 (16.4)

32 (12.0)

 

 > = 225

156 (26.9)

73 (6.1)

 

32 (25.0)

25 (9.4)

 

Anaesthesia time (min)

  

<.001

  

<.001

 < 190

41 (7.1)

353 (29.5)

 

11 (8.6)

92 (34.5)

 

 190–239.99

202 (34.8)

638 (53.3)

 

52 (40.6)

144 (53.9)

 

 > = 240

337 (58.1)

205 (17.2)

 

65 (50.8)

31 (11.6)

 

Cardiopulmonary bypass time (min)

  

<.001

  

<.001

 < 65

68 (11.7)

555 (46.4)

 

18 (14.1)

147 (55.1)

 

 65–94.99

184 (31.7)

519 (43.4)

 

40 (31.2)

101 (37.8)

 

 95–134.99

218 (37.6)

105 (8.8)

 

47 (36.7)

18 (6.7)

 

 > = 135

110 (19.0)

17 (1.4)

 

23 (18.0)

1 (0.4)

 

Aortic occlusion time (min)

  

<.001

  

<.001

 < 25

40 (6.9)

301 (25.1)

 

9 (7.1)

79 (29.6)

 

 25–54.99

239 (41.2)

770 (64.4)

 

51 (39.8)

164 (61.4)

 

 > = 55

301 (51.9)

125 (10.5)

 

68 (53.1)

24 (9.0)

 

Operation time (min)

  

<.001

  

<.001

 < 110

3 (0.5)

64 (5.4)

 

1 (0.8)

22 (8.2)

 

 110–179.99

248 (42.8)

910 (76.0)

 

61 (47.7)

220 (82.4)

 

 > = 180

329 (56.7)

222 (18.6)

 

66 (51.65)

25 (9.4)

 

Intraoperative blood transfusion

  

<.001

  

<.001

 YES

264 (45.5)

166 (13.9)

 

59 (46.1)

215 (80.5)

 

 NO

316 (54.5)

1030 (86.1)

 

69 (53.9)

52 (19.5)

 

Preoperative total protein content (g/L)

  

0.03

  

0.038

 < 59

99 (17.1)

158 (13.2)

 

18 (14.1)

20 (7.5)

 

 > = 59

481 (82.9)

1038 (86.8)

 

110 (85.9)

247 (92.5)

 

Preoperative albumin (g/L)

  

0.509

  

0.486

 < 39

15 (2.6)

25 (2.1)

 

5 (3.9)

7 (2.6)

 

 > = 39

565 (97.4)

1171 (97.9)

 

123 (96.1)

260 (97.4)

 
  1. PAH Pulmonary hypertension, PI Pulmonary infection, non-PI Non- pulmonary infection